Articles tagged with Colon Cancer
A preliminary study found that most elderly patients with stage II and III colon cancer survive short-term surgery, but those with unplanned hospital admissions and open operations face higher mortality rates. Experienced surgeons who perform high-volume procedures also reduce the risk of death.
Researchers found complex patterns of mutations, including changes in cancer genes, and a huge variability of mutations in healthy colon tissue. The study provides insight into how a healthy cell becomes a cancerous one and identifies new mutational signatures in normal colon cells.
Researchers found that disrupting the PTPN2 gene boosts anti-tumor immunity, enabling cancer clearance in animal models. Deleting the gene stimulates production and fitness of T-killer cells, which are critical in warding off tumors.
A Norwegian study found that being overweight before age 40 significantly increases the risk of several types of cancer, including endometrial cancer by 70%. Obesity is also linked to an increased risk of postmenopausal breast, renal-cell and colon cancers.
A Colorado study found that lymphoma stage at diagnosis impacts types of second cancers that may form after treatment. Early-stage patients had a higher risk of solid tumors, while late-stage patients were more likely to develop hematologic malignancies.
Researchers at George Washington University found a connection between specific bacteria in the microbiome and the development of colon cancer. The study suggests that altered microbial profiles may be used to identify risk for colon cancer, particularly in younger patients.
New studies show that KRAS gene mutations, common in colorectal and other cancers, vary in disease severity depending on the specific mutation and tissue location. The findings suggest that precision medicine approaches must be tailored to individual mutant forms of KRAS.
Researchers at UMass Amherst discover that consuming fried foods can exacerbate conditions of the colon, including colonic inflammation and tumor growth. The study suggests that eating fried foods may make diseases like IBD more aggressive in susceptible individuals.
Researchers at Johns Hopkins Kimmel Cancer Center found that taking a single course of antibiotics may boost the risk of developing colon cancer a decade later. The study, published in the journal Gut, highlights the need for judicious use of antibiotics and careful stewardship.
Researchers at the University of Arizona Cancer Center successfully repeated findings from a study that challenged current approaches to colon cancer treatment. The team validated therapeutic targeting of LRP6 as a potential strategy for blocking progression of colon cancer, offering new hope for patient care.
Researchers at the University of Minnesota Medical School have identified a cellular mechanism that contributes to drug resistance in colon cancer. The study found that KRAS proteins can transfer between cancer cells via long, thin extensions called tunneling nanotubes, leading to more aggressive and invasive cancer behavior.
A new iPad app, mPATH-CRC, will be tested in North Carolina and Kentucky clinics to increase colorectal cancer screenings. The project aims to determine the optimal way to implement technology-based programs to improve medical care delivery.
Researchers from the University of Missouri School of Medicine found no significant difference in colonoscopy detection rates between moderate and deep sedation methods. Moderate sedation, typically used in colonoscopies, was found to be equally effective as deep sedation in detecting pre-cancerous polyps.
A researcher is using a $2.3 million grant to study the mechanisms by which bacteria in the colon may trigger cancer development. The goal is to develop prevention strategies, such as probiotics, to stop the triggering of the immune response.
Early-onset colorectal cancer incidence has been increasing rapidly in Western US states, despite low rates of smoking and physical inactivity. The study found that rates rose faster for rectal tumors than colon tumors, with average increases exceeding 2.5% per year in ten states.
Researchers found that strawberry tree honey reduces colon cancer cell proliferation and colony formation ability by regulating EGFR and MAPKs signaling pathways. The study also showed that the honey inhibits cell cycle, induces apoptosis, and suppresses key genes involved in tumor growth.
The study found significant increases in colon and rectal cancer incidence among young adults in several high-income countries, including Australia, Canada, Denmark, Ireland, New Zealand, Norway, and the UK. The incidence of colon cancer increased significantly each year in people aged 0-49 years, while rectal cancer incidence was most...
Researchers analyzed colon cancer proteins and genes, uncovering novel biological mechanisms and potential new therapeutic strategies. The study provides a systematic catalog of proteins produced by colon cancer tumors and adjacent normal tissues, including insights into unexpected gene behavior.
A novel colorectal cancer vaccine has demonstrated positive phase I results, with patients showing no signs of serious adverse events and activation of immune cells. The vaccine was found to be safe and effective in a small sample of human subjects, paving the way for further testing to determine its potential as a treatment.
Scientists successfully blocked cancer-fighting gene silencing protein UHRF1, restoring hundreds of protective genes in human colon cancer cells. The findings suggest a new strategy for fighting cancers by targeting this protein.
Researchers developed a novel cell model of aging-related colon cancer risk by combining genetic and epigenetic factors. The model shows that epigenetic changes are essential for cancer initiation, and can be used to assess cancer risk in human lab-grown cells.
A team of University of Wisconsin-Madison scientists has identified four blood-based fingerprints associated with pre-cancerous forms of colon cancer. The findings may lead to a minimally-invasive blood test to increase screening rates and reduce overtreatment.
Researchers at Oregon State University discovered that two hop-derived compounds inhibit liver and colon cancer cell growth effectively similar to xanthohumol. These non-estrogenic derivatives offer promising alternatives for future preclinical studies.
Starting colorectal cancer screening at age 45 rather than 50 would decrease U.S. cancer deaths by as much as 11,100 over five years and cases by up to 29,400. Screening a greater number of older adults would avert nearly three times as many diagnoses and deaths at a lower cost.
A study by Weill Cornell Medicine found that consuming high-fructose corn syrup causes mice with colon cancer to develop larger tumors. The researchers discovered a molecular mechanism by which the sweetener fuels tumor growth and suggest blocking this effect could lead to new cancer treatments.
Researchers found that early-life microbiota play a crucial role in regulating immune responses and preventing colon cancer in adulthood. The absence of microbiota in early life can lead to enhanced pro-inflammatory gene expression and an accumulation of immune cells that suppress tumor growth.
A study published in EMBO Reports found that the common oral bacterium F. nucleatum accelerates colon cancer growth by inducing the production of protein Annexin A1, which stimulates cancer cell growth. This discovery may help predict aggressive colon cancers and identify new treatment targets.
Research published in The Journal of Physiology suggests that exercise may play a role in inhibiting the growth of colon cancer cells. After high-intensity interval training (HIIT), growth was reduced and inflammation increased, indicating a potential anti-cancer effect. This study highlights the importance of regular physical activity...
Researchers at UMass Amherst have discovered a novel therapeutic target, CYP monooxygenase pathway, that could prevent or treat colon cancer. The study found that certain fatty acid metabolites, such as epoxyoctadecenoic acids (EpOMEs), increase inflammation and tumor growth in the colon.
The study found a substantial increase of 230% in colon cancer screenings among Medicaid patients post-ACA expansion. Additionally, data showed a 9.3% rise in early-stage colon cancer diagnosis and a 27% decrease in risk of death.
Researchers at Penn State College of Medicine identified 10 synthetic cannabinoid compounds that effectively inhibited the growth of seven types of human colon cancer cells. These compounds work through alternative mechanisms, not relying on traditional marijuana receptors, and hold promise for developing drugs to treat cancer.
A study published in Cell Reports reveals a critical connection between chronic inflammation and the development of colon cancer. Researchers found that persistent inflammation leads to increased levels of myeloid-derived suppressor cells and interleukin-10, which ultimately silence tumor suppressors and contribute to cancer growth.
Colorectal cancer mortality rates are projected to decrease in most countries, but increase in Europe, North America, and Oceania. The number of deaths is expected to rise globally by 60.0% and 71.5% until 2035.
Researchers found that it took a year or more from first spotting a symptom to beginning treatment for 10% of patients in England, Northern Ireland, and Wales. The time to diagnosis varied significantly across countries, with Denmark performing the best.
A systematic review and meta-analysis found that racial differences in colorectal cancer incidence are not due to biological factors. The study suggests that screening should begin at age 50 regardless of race, with consideration for individual risk factors and preferences. Improved access to screening is crucial to reducing disparitie...
Researchers report a 100% major pathological response rate in early-stage colon cancers with mismatch repair deficiencies treated with nivolumab and ipilimumab. The regimen was well-tolerated, and patients underwent radical resection without delays.
A new study found that inflammatory proteins in the colon increase incrementally with weight in humans, leading to pro-cancerous changes. The study also suggests that NSAIDs may lower the levels of these pro-inflammatory proteins, reducing cancer risk.
Researchers at CWRU School of Medicine are exploring the role of long noncoding RNAs in colon cancer. They have identified potential targets for treatment, including lincDUSP, and found that depleting its levels can slow tumor growth.
A study found that bacteria in the intestines fuel tumor growth in the colon, with chronic inflammation having no effect on cancer development. Microbial therapy is considered a promising approach when more about bacterial flora composition is known.
Scientists from the University of Luxembourg have identified a molecular mechanism responsible for colon cancer cell spread and metastasis. A small molecule cluster, miR-371~373, was found to regulate colon cancer metastasis in aggressive, fast-growing cancer cells. Reactivation of this cluster slowed down metastatic cell growth.
A clinical trial found that using an anti-inflammatory agent during surgery can reduce inflammation and tumor cell growth, potentially improving cancer outcomes. The study tested a solution containing Taurolidine in patients undergoing surgery for colon cancer.
A study from the Francis Crick Institute found that chemicals produced by vegetables like kale and broccoli can prevent colon cancer in mice. The research discovered that these compounds activate a protein called AhR, which helps protect against inflammatory responses to gut bacteria.
Researchers found distinct genetic mutations in appendix cancer that predict survival rates and may impact therapy choices. The study identified specific genes, such as TP53 and GNAS, as biomarkers for high-risk patients.
A large-scale retrospective study has shown that nearly doubling the number of lymph nodes removed during operations for right-sided colon cancers improves the survival rate for these patients. The study found improved outcomes when at least 22 lymph nodes were harvested, with a 20% increase in five-year survival rates.
A Yale University study found that drinking artificially-sweetened beverages is associated with a significantly lower risk of colon cancer recurrence and death. Participants who drank one or more 12-ounce servings of artificially sweetened beverages per day experienced a 46% improvement in risk, compared to those who didn't.
Researchers at Boston University School of Medicine have identified c-Cbl as a potential target protein in colon cancer. High levels of c-Cbl were found to be associated with longer patient survival rates.
A new study by IRB Barcelona researchers reveals that myeloid cells use p38 protein signalling to support inflammation-associated colon cancer. The study suggests IGF-1 as a potential therapeutic target in combination with prior detection of inflammatory infiltration in biopsies.
A research team, led by OHSU physician-scientists, has discovered a drug compound that inhibits cancer cell movement and prevents them from spreading throughout the body. The compound was developed using a multidisciplinary approach, combining chemistry and biology to create a highly effective therapeutic.
The Immunoscore test accurately predicts tumor recurrence risk in patients with colon cancer, enabling intensified treatment after surgery. The test identifies two types of immune cells in the tumor and its invasive margin, providing a reliable estimation of disease progression.
A UCLA-led study found how colon cancer alters its genes to avoid detection by the immune system. The ability of cancer to change its genes, called immunoediting, had never been described in colon cancer before.
Researchers discovered that aspirin blocks TIF-IA, a molecule essential for the nucleolus to function, driving tumour formation and dysfunction. Regular use of aspirin may help pinpoint those most likely to benefit from the treatment.
Researchers found that triclosan causes colon inflammation and worsens colon cancer in mice, raising concerns about its safety for human consumption. The study suggests that individuals with inflammatory bowel disease or colon cancer may be more vulnerable to the chemical's adverse effects.
A new mouse study suggests that the widely used antimicrobial ingredient triclosan may have adverse effects on colonic inflammation and colon cancer. Researchers found that triclosan altered gut microbiota, increased inflammation, and spurred disease development in mice.
Research suggests that being overweight in childhood and having above-average weight gain during puberty increases the risk of developing adult colon cancer in men. However, this risk is not present for boys who do not experience significant weight gain during puberty.
Researchers discovered that colon cancer cells rely on unusually long RNA strands, called lincRNAs, to evade cell death and promote unregulated growth. Targeting these molecules could lead to effective treatments.
Early-stage colon cancers can be surgically removed but later stages require targeted treatments. Researchers discovered that colon cancers are composed of two different cell types with the ability to replace each other after one is killed.
Researchers discovered colon cancers are composed of two different cell types that can replace each other when one is killed. Targeting both cell populations simultaneously showed strong repressive effects on tumor cell proliferation and increased cell death, resulting in slower tumor growth and prolonged survival times.
A study published in the International Journal of Cancer found that regularly eating red meat increases the risk of distal colon cancer in women, with those on a red meat-free diet experiencing lower rates. The research suggests that a diet free from red meat significantly reduces the risk of this type of colon cancer.
A lifestyle consistent with American Cancer Society (ACS) guidelines was associated with a lower risk of death in patients with stage III colon cancer. Patients who followed these guidelines had improved survival rates compared to those who did not.
Two common iron compounds, ferric citrate and ferric EDTA, have been shown to increase the formation of a known biomarker for cancer, amphiregulin. This is the case even at low doses. The study suggests that these iron supplements may be carcinogenic.